OncoMatch/Clinical Trials/NCT05820126
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial
Is NCT05820126 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies Cold-stored platelet concentrate for hematologic malignancy.
Treatment: Cold-stored platelet concentrate — This is a pilot trial to discover the feasibility of recruiting 50 pts over the course of 12 months. The trial is testing the efficacy of using cold-stored vs. room temperature stored (current standard of care) platelets to treat bleeding in persons with hematological disorders and thrombocytopenia.
Check if I qualifyExtracted eligibility criteria
Cancer type
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Non-Hodgkin Lymphoma
Multiple Myeloma
Myelodysplastic Syndrome
Chronic Lymphocytic Leukemia
Lab requirements
Blood counts
Moderate thrombocytopenia, platelet concentration 10-100 x109/L; Exclude if severe thrombocytopenia (platelet concentration <10 x 109/L)
Moderate thrombocytopenia, platelet concentration 10-100 x109/L; Severe thrombocytopenia (platelet concentration <10 x 109/L) [excluded]
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify